Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
46.28
+1.23 (2.73%)
Oct 23, 2026, 3:00 PM CST
| Market Cap | 8.03B -14.6% |
| Revenue (ttm) | 1.34B +0.1% |
| Net Income | 277.24M +21.4% |
| EPS | 1.60 +23.1% |
| Shares Out | 173.57M |
| PE Ratio | 28.92 |
| Forward PE | 27.64 |
| Dividend | 0.49 (1.06%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 1,518,026 |
| Open | 44.70 |
| Previous Close | 45.05 |
| Day's Range | 43.85 - 46.44 |
| 52-Week Range | 40.25 - 80.48 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |